Molecular Biomarkers of Oxygen Therapy in Patients... (2021 study) Skip to main content
Review Biomolecules 2021

Molecular Biomarkers of Oxygen Therapy in Patients with Diabetic Foot Ulcers.

Oropallo AR, Serena TE, Armstrong DG, Niederauer MQ, Biomolecules, 2021

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The authors wrote a narrative review of how oxygen therapy, including hyperbaric oxygen therapy (HBOT) and topical oxygen therapy, relates to wound healing and to molecular markers in diabetic foot ulcers.

What They Found

This narrative review of oxygen therapy in diabetic foot ulcers describes how oxygen is thought to act in wound healing and which molecular biomarkers have been identified, without reporting trial figures. The abstract says the data suggest oxygen therapy promotes wound healing through angiogenesis, the creation of new blood vessels. It says certain biomarkers have been linked to angiogenesis and inflammation, which it calls two crucial parts of wound healing. It also describes clinical outcomes such as collagen formation, angiogenesis, respiratory burst and cell proliferation, and it states that oxygen therapy benefits some patients, not all.

What This Means for Canadian Patients

For people with diabetic foot ulcers, the abstract says oxygen therapy is currently guided by clinical examination and imaging. It says predictive biomarkers can be used to identify patients most likely to benefit, but it does not report that this has changed care. The abstract gives no treatment pressures, session numbers or patient results.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This is a narrative review, not a trial, so it reports no patient numbers or measured treatment effects, and the abstract does not describe how the evidence was selected.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Review
Category Wound Care
Source Pubmed
PubMed ID 34206433
Year Published 2021
Journal Biomolecules
MeSH Terms Administration, Topical; Biomarkers; Cell Proliferation; Diabetic Foot; Humans; Hyperbaric Oxygenation; Oxygen; Wound Healing

Cite This Study

Share

This study relates to Problem Wounds. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology